Health

Nippon Express (China) Participates in 11th Global Pharmaceutical Cold Chain Summit

TOKYO, Sept. 26, 2022 /PRNewswire/ -- Nippon Express (China) Co., Ltd. (hereinafter "NX China"), a group company of NIPPON EXPRESS HOLDINGS, INC., participated in the three-day 11th Global Pharmaceutical Cold Chain Summit hosted by the China Federation of Logistics & Purchasing and held inChongqi...

2022-09-26 15:00 460

MGI Launches Ultra High Speed DNBSEQ-G99 Gene Sequencer* with Mid to Low Range Throughput

SHENZHEN, China, Sept. 26, 2022 /PRNewswire/ -- MGI Tech Co., Ltd. (MGI) on 9 September officially launched DNBSEQ-G99*, the latest model of the gene sequencer* with mid to low range throughput.  As one of the sequencers* with the fastest speed among those with the same throughput in the world, ...

2022-09-26 15:00 391

CellResearch Corporation (CRC) to present promising new stem cell products for the treatment of chronic diabetic foot ulcers at the world's premier diabetic foot conference (DFCon) in Los Angeles

-  CRC data on cord lining media for the treatment of diabetic foot ulcers has been accepted at the DFCon, with DrWong Keng Lin Francis, CRC's latest KOL, presenting his findings to world leaders in the field of DFU. -  Similarly, the results of Corlicyte™'s Phase 1 study on the treatment of chro...

2022-09-26 13:44 522

CellOrigin Biotech Announces Global Strategic Collaboration with Qilu Pharma to Develop "Off-the-Shelf" CAR-iMAC Cell Therapy

HANGZHOU, China, Sept. 26, 2022 /PRNewswire/ -- CellOrigin Biotech (Hangzhou) Co., Ltd. announced it has made a global strategic collaboration agreement with Qilu Pharma to develop, manufacture and commercialize proprietary "off-the-shelf" induced pluripotent stem cell- (iPSC) derived Chimeric An...

2022-09-26 12:31 618

Everest Medicines Receives Approval of Investigational New Drug Application from China NMPA for EVER001, a Novel BTK Inhibitor in Development for Treatment of Renal Diseases

Advancement highlights Everest's potential in providing first-in-class therapies to global patients with glomerular disease SHANGHAI, Sept. 26, 2022 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focu...

2022-09-26 08:00 674

AAHRPP Accredits Five More Research Organizations, Including First in Japan

WASHINGTON, Sept. 24, 2022 /PRNewswire/ -- The Association for the Accreditation of Human Research Protection Programs has accredited five more research organizations, including its first organization inJapan, two public research universities, a children's hospital and an acute-care hospital. At...

2022-09-24 01:22 1472

TCT2022| Pulnovo Medical Announced That The Latest Results Of PADN-CFDA Pivotal Trial Indicate Effectiveness And Safety of PADN For The Treatment Of Pulmonary Arterial Hypertension (PAH)

SHANGHAI, Sept. 23, 2022 /PRNewswire/ -- Pulnovo Medical Limited, a globally recognized OTM platform, today announced the positive results from the Pulmonary Artery Denervation (PADN)-CFDA pivotal study on the world's largest and most influential American transcatheter cardiovascular therapy conf...

2022-09-23 20:30 1169

'iSyncWave' EEG Scanner receives FDA 510k clearance

SEOUL, South Korea, Sept. 23, 2022 /PRNewswire/ -- iMediSync announced that iSyncWave, the company's medical device EEG scanner, has been granted510k clearance from the US Food and Drug Administration (FDA) onAugust 10th. iMediSync’s EEG scan...

2022-09-23 17:57 717

Hummingbird Bioscience Holds Opening Ceremony for Singapore Science Park Office and Research Facilities

SINGAPORE, Sept. 23, 2022 /PRNewswire/ -- Hummingbird Bioscience, a data-driven precision biotherapeutics company discovering and developing transformative biologic medicines for hard-to-treat diseases, today announced the official opening of its office and research facilities at the Singapore Sc...

2022-09-23 17:00 1003

Mentice AB (publ) receives an order of USD 620,000 for simulation solutions and development services

GOTHENBURG, Sweden, Sept. 23, 2022 /PRNewswire/ -- Mentice AB (publ), Gothenburg , a world leader in simulation solutions for image-guided interventional therapies, announced today that a leading global healthcare technology company, has signed an agreement to acquire Mentice VIST® simulation solu...

2022-09-23 14:10 935

111, Inc. Announces Appointment of Independent Financial Advisor and Legal Counsel to the Special Committee

SHANGHAI, Sept. 23, 2022 /PRNewswire/ -- 111, Inc. ( "111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company in China, announced today that the special committee (the "Special Committee"), consisting of three independent directors, Mr.Jian Sun, who is the chairman...

2022-09-23 12:30 867

USANA Philippines Earns Three Major Awards for Corporate Excellence

MANILA, Philippines, Sept. 23, 2022 /PRNewswire/ -- USANA Health Sciences, Inc., a leader in global nutrition, applauds itsPhilippines market for being recently honored with three regional awards. Two from the Asia Responsible Enterprise Awards (AREA) and one from HR Asia Best Companies to Work. ...

2022-09-23 09:00 2040

Shandong Proton Center Celebrates Milestone in Delivering High-Quality Proton Treatment

BEIJING, Sept. 23, 2022 /PRNewswire/ -- On July 20, 2022, the Shandong Proton Center (SDPT) treated the first four participants enrolled in a clinical trial, marking a key milestone on the path to expanding access to advanced cancer care – including proton therapy – inChina. Proton therapy can b...

2022-09-23 08:00 940

WINNERS OF THE 2023 BREAKTHROUGH PRIZES IN LIFE SCIENCES, MATHEMATICS AND FUNDAMENTAL PHYSICS ANNOUNCED

$15.75 Million in Prizes Awarded for Predicting Protein Structure with Deep Learning, Pioneering Field of Quantum Information, and Discoveries with Applications from Treating Neurodegenerative Disease to Optimizing Video Transmission Breakthrough Prize in Life Sciences Awarded to Clifford P. Bra...

2022-09-22 21:25 1160

Frost & Sullivan Explores the Growing Impact of the Digital Front Door on Healthcare

Digital front door creates a new, consumer-centric paradigm in healthcare while improving patient satisfaction SAN ANTONIO, Sept. 22, 2022 /PRNewswire/ -- In just a few short years, the digital front door has shifted from being a nice-to-have online presence to being a critical part of every hea...

2022-09-22 17:14 894

NIA Accelerates Thai FoodTech Startups to Steer Bangkok Towards Becoming FoodTech Silicon Valley Through SPACE-F Project

BANGKOK, Sept. 22, 2022 /PRNewswire/ -- The National Innovation Agency (Public Organization),Thailand or NIA continues its support in scaling up the FoodTech startups through the 2022 edition of the "SPACE-F" project. With aims to encourage investment opportunities for the Thai food sector and en...

2022-09-22 15:47 2402

Clarivate Supports Peer Review Week by Raising the Profile of Peer Reviewers

Recognizing peer review via the next generation of Web of Science Researcher Profiles LONDON, Sept. 22, 2022 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today celebrates Peer Review Week with the ...

2022-09-22 15:00 772

Agilis Robotics Targeting its Pre-B Round Fund-raising to be Completed by 2022

Successful In Vivo Testing Clears the Way for First Human Trial in Near Future HONG KONG, Sept. 22, 2022 /PRNewswire/ -- Agilis Robotics Limited ("Agilis Robotics" or the "Company"), the creator of the first surgical robotic instruments inHong Kong to target endoscopic submucosal dissection (ESD)...

2022-09-22 14:31 931

Cellenkos Receives FDA Clearance of Investigational New Drug (IND) Application for CK0803 for the Treatment of Amyotrophic Lateral Sclerosis (ALS)

-- CK0803 are neurotropic, allogeneic, umbilical cord blood derived T regulatory (Treg) cells -- CK0803 represents the company's fifth program to receive IND Clearance utilizing Cellenkos' proprietaryCRANE™ technology HOUSTON, Sept. 22, 2022 /PRNewswire/ -- Cellenkos, Inc., a clinical stage bio...

2022-09-22 13:59 839

China CDE Grants CMG901 Breakthrough Therapy Designation for Claudin 18.2-Positive Advanced Gastric & Gastroesophageal Junction Cancer

CHENGDU, China, Sept. 22, 2022 /PRNewswire/ -- Keymed Biosciences (HKEX:02162) announced that the Center for Drug Evaluation (CDE) of the China National Medical Products Administration (NMPA) has granted CMG901 the Breakthrough Therapy Designation for the treatment of advanced gastric and gastroe...

2022-09-22 13:05 597
12345 ... 686